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http://dx.doi.org/10.1016/j.asjsur.20Summary Objective: Carcinoid tumors of the lung are rare, and account for 1% of all primary
tumors of the lung. This study was undertaken to investigate the histological characteristics
and clinical behavior of carcinoid tumors of the lung.
Methods: We have retrospectively reviewed the hospital records of 11 consecutive patients
undergoing surgical treatment for carcinoid tumors of the lung between 1992 and 2007.
Results: Patients with carcinoid tumors accounted for 0.8% (11 of 1319) of the patients under-
going surgical treatment for nonsmall cell lung cancer. The group comprised six males and five
females with a mean age at presentation of 58.6 years (range 27e78 years). All of the opera-
tions were lobectomies, including two sleeve lobectomies. Six patients had typical and five had
atypical carcinoid tumors. Seven patients had stage IA disease, two had stage IB, one had stage
IIA, and one had stage IIIA. Recurrent tumors developed in two of the five patients affected by
atypical carcinoid tumors, but none of the six patients with typical carcinoid tumors. Overall,
the 5-year survival rate of patients with both typical and atypical carcinoid tumors was 90.9%.
Conclusion: Survival of carcinoid tumors was favorable. In this analysis, two patients with
atypical carcinoid had postoperative recurrences. Recurrence was more common among
patients with atypical carcinoid tumors.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Chest Surgery, Kitakyushu
u, Kokurakita-Ku, Kitakyushu
-u.ac.jp (Y. Ichiki).
n Surgical Association. Published
12.11.0071. Introduction
The distinction between typical and atypical carcinoid
tumors was first described by Engelbreth-Holm1; the
histological criteria for this distinction were later estab-
lished by Arrigoni et al.2 The initial classification of these
tumors established by the World Health Organization
(WHO)3 in 1982 has been amended various times. As aby Elsevier Taiwan LLC. All rights reserved.
Table 1 Patients’ characteristics.
No. of patients (%)
Gender Male 5 (45)
Female 6 (55)
Age (y) 27e78 (mean Z 58.6)
Symptom Cough 3 (27)
Hemosputum 1 (9)
Asymptomatic 7 (64)
Location Rt upper lobe 5 (45)
Rt middle lobe 1 (9)
Rt lower lobe 1 (9)
Lt upper lobe 4 (36)
Lt lower lobe 0
Central type 4 (36)
Peripheral type 7 (64)
Histology Typical carcinoid 6 (55)
Atypical carcinoid 5 (45)
Procedure Lobectomya 11 (100)
Curability Complete resection 11 (100)
Incomplete resection 0 (0)
p T stage T1 8 (73)
T2 3 (27)
p N stage N0 9 (82)
N1 1 (9)
N2 1 (9)
p stage IA IA 7 (64)
IB 2 (18)
IIA 1 (9)
IIIA 1 (9)
Total 11
Lt Z left; Rt Z right.
a Including two sleeve lobectomies.
Carcinoid tumors of the lung 117result of clinical and prognostic disputes, new histological
criteria proposed by Travis et al4 to separate typical and
atypical carcinoid tumors have recently been considered
and accepted by the WHO and the International Associa-
tion for the Study of Lung Cancer (IASLC) in the 1999
classification of lung tumors.5 At present, the investigation
of these pathological processes centers on the causes of
their specific differentiation, behavior, and treatment
options.
We review our experience with 11 patients and investi-
gated the histological characteristics and clinical behavior
of carcinoid tumors of the lung.
2. Patients and methods
2.1. Patients
We retrospectively reviewed our experience with the
surgical treatment of both typical and atypical carcinoid
tumors of the lung. Eleven patients who underwent thora-
cotomy between 1992 and 2007 at the Kitakyushu Municipal
Medical Center, Fukuoka, and had a final histologic diagnosis
of a carcinoid tumor of the lung were analyzed. Thirty-day
mortality was defined as a fatality within 30 days after
pulmonary resection, and in-hospitalmortality (not including
30-day mortality) was defined as a fatality occurring at any
time during the postoperative hospital stay.
Tumors were classified according to the current WHO/
IASLC criteria for neuroendocrine tumors.6 Typical carci-
noids are defined as tumors greater than 5 mm in diameter,
with carcinoid morphology and less than two mitoses per
2 mm2, and lacking necrosis. Tumors with a mitosis rate of 2
or more but less than 10 per 2 mm2, with or without
necrosis, were classified as atypical carcinoids. The final
pathological stage was classified according to the general
rules for the clinical and pathological record of lung cancer
(the seventh edition).7 A complete resection, classified as
R0, was defined as the pathological demonstration of
negative tissue margins and assessment by the surgeon that
all detectable diseases had been removed.
2.2. Patient follow-up
The records of the patients were reviewed for preoperative
symptoms, surgical procedures performed, and post-
operative complications. The patients were followed up at
1- or 3-month intervals for 5 years or more. Physical
examinations, routine hematological analyses, chest radi-
ographies, computed tomography (CT) scans of the chest
and upper abdomen, magnetic resonance images of the
brain, and bone scintigraphy were performed for evalua-
tions of recurrence.
The survival rates were calculated using the
KaplaneMeier method, and the significance of the differ-
ences in these rates was evaluated with the log-rank test.
3. Results
Patients with carcinoid tumors accounted for 0.8% (11 of
1319) of the patients undergoing surgical treatment fornonsmall cell lung cancer. The patients’ characteristics are
presented in Table 1. The group comprised six males (55%)
and five females (45%) with a mean age at presentation of
58.6 years (range 27e78 years). Symptoms were present in
four (36%) patients and included cough (n Z 3) and
hemoptysis (n Z 1). Seven (64%) patients were asymp-
tomatic at presentation. Carcinoid syndrome was not
observed in any of the patients. The tumor was in the right
lung in seven patients and in the left lung in four. Seven
tumors were peripherally located. The other four tumors
were centrally located. All operations performed were
lobectomies including two sleeve lobectomies. All patients
had R0 resections. Six patients (55%) had typical and five
(45%) had atypical carcinoid tumors (Table 2). Seven
patients had pathological stage IA disease, two had stage
IB, one had stage IIA, and one had stage IIIA. The overall 5-
year survival of patients with both typical and atypical
carcinoid tumors of the lung was 90.9% (Fig. 1). Both the 30-
day and in-hospital mortality were 0%. Recurrent tumors
developed in two of the five patients affected by atypical
carcinoid, but none of the six patients with typical carci-
noid tumors (Fig. 2). One patient developed mediastinal
lymph node metastasis at 20 months after the operation,
and she underwent radiotherapy to the mediastinum
(60 Gy). Brain metastasis subsequently developed at 25
months and gamma knife therapy was performed. However,
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Figure 1 Survival curve of operation for carcinoid tumors.
Hash marks represent censored patients.
118 Y. Ichiki et al.the patient was found to have lung metastasis and pleuritis
carcinomatosa at 28 months, and died at 40 months post-
operatively. Another patient is still alive 30 months post-
operatively despite liver metastasis. He suffered from
a cerebral infarction after being the discharged and
thereafter was followed without any particular treatment.4. Discussion
Carcinoid tumors of the lung comprise 1e2% of all lung
malignancies. Historically called bronchial adenomas, they
were thought to be benign tumors.8e10 The recognition of
a more progressive variety of carcinoid tumors, the atypical
carcinoid tumors, suggested that they might all be malig-
nant.2,4,11e13 Currently, typical and atypical carcinoids are
considered to be part of a spectrum of malignant neoplasms
with neuroendocrine differentiation along with large cell
neuroendocrine carcinoma and small cell carcinoma.4,5,12
In general, patients with typical carcinoid tumors have
good prognoses, with >87% of patients surviving for
10 years. In contrast, approximately 25e69% of patients
with atypical carcinoid tumors survive for 5 years, and
many develop widespread disease.2,4,10,13e20 Multivariate
analyses from several studies have suggested that the
pathological stage and atypical histology are the most
important factors affecting survival.4,13,15,18 By contrast,1 2 3 4 5
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1 Typical carcinoid
Atypical carcinoid
Figure 2 Survival curve of operation for typical and atypical
carcinoid tumors. Hash marks represent censored patients.
Carcinoid tumors of the lung 119according to the data of 661 patients with typical or atyp-
ical tumors of the lung, no difference in survival was
observed between typical and atypical carcinoid in patho-
logical stage IA, although a difference was found in stage
IB. However, in a multivariate analysis, a factor of typical
or atypical carcinoid tumors of the lung is one of the
significant factors influencing survival,21 and surgical
treatment for early-stage atypical carcinoid tumors might
provide a better outcome. In this study, postoperative
recurrence and tumor-related death were seen for atypical
carcinoid tumors but not for typical carcinoid tumors.
However, two of five atypical carcinoid tumors of the lung
were pathological stage IA, and both patients had no
postoperative recurrence.
The radiological studies in our patients showed
a predominance of peripheral nodules (64%). Central
nodules were seen in 36% of the patients. Choplin et al22
reported that a round or ovoid, lobulated peripheral mass
was the most common radiologic presenting feature of
atypical carcinoid tumors (80%). Wilkins et al23 revealed
that 60% of their patients with peripheral bronchial carci-
noid tumors had atypical carcinoid tumors. Our data
showed that 57% of peripheral carcinoid tumors of the lung
were atypical carcinoid tumors. Forster et al24 suggested
that tumor size may be a prognostic factor for the differ-
entiation of neuroendocrine lung tumors. They concluded
that any tumor measuring more than 2.5 cm on a CT scan is
more likely to be an atypical carcinoid tumor than a typical
carcinoid tumor.
The assessment of the biological behavior of bronchial
carcinoid tumors is not always accurate. Atypical carcinoid
tumors present more often at a more advanced stage, are
more likely to recur, and are associated with lower 5- and
10-year survival rates than typical carcinoid tumors. These
findings reveal the need for more accurate differentiation
between histological subtypes. Strict application criteria
are mandatory to allow for distinction between the typical
and atypical subtypes, which could influence surgical
management.
It has been reported that the appropriate surgical
management of bronchial carcinoid tumors is suggested by
their recurrence and survival patterns.4,19,25e30 Limited
resection such as wedge resection or segmentectomy for
peripheral tumors and isolated bronchial sleeve resection
or sleeve lobectomy for central tumors should be consid-
ered when feasible for early-stage typical bronchial carci-
noid tumors because local recurrence is unlikely and
survival is excellent. We did not investigate the use of
endobronchial laser therapy for localized central typical
carcinoids. Because of the excellent results of standard
surgical therapy for such tumors and the risk of local
recurrence when laser modalities are used, we favor
resection except in patients who are deemed to be at
excessive risk.
Long-term survival and local recurrence are both unfa-
vorably affected by the finding of atypical histology. We
think a more aggressive surgical approach including formal
lobectomy (or pneumonectomy when indicated) and lymph
node dissection should be performed when this histology is
identified. The potential benefits of postoperative adjuvant
chemotherapy and/or radiation therapy also should be
considered, especially for atypical carcinoid tumors.5. Conclusion
This study suggested that survival of carcinoid tumors of the
lung was favorable. Atypical carcinoid tumors showed
a more malignant potential in their clinical behavior.References
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